Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-035400
Filing Date
2026-03-26
Accepted
2026-03-26 20:00:11
Documents
1
Period of Report
2026-03-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm269848-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm269848-1_4seq1.xml 4 4257
  Complete submission text file 0001104659-26-035400.txt   5744
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814
Business Address
Fuggetta Gianluca (Reporting) CIK: 0001958188 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40237 | Film No.: 26800457